Controversies Regarding the Use of Radiation After Mastectomy in Breast Cancer
- 1 December 2002
- journal article
- review article
- Published by Oxford University Press (OUP) in The Oncologist
- Vol. 7 (6) , 539-546
- https://doi.org/10.1634/theoncologist.7-6-539
Abstract
Learning Objectives: After completing this course, the reader will be able to:Explain the potential benefits of delivering radiation after mastectomy for patients with breast cancer.Provide a list of appropriate indications for selecting which patients would benefit from radiation after mastectomy and chemotherapy.Appreciate how radiation can potentially cause cardiovascular injuries and understand the importance of radiation technique in minimizing the risk for such injuries.Appreciate how immediate breast reconstruction can affect the delivery of postmastectomy radiation. Access and take the CME test online and receive one hour of AMA PRA category 1 credit at CME.TheOncologist.com Despite years of clinical study, there are still many unanswered questions regarding postmastectomy radiation. It is clear that radiation therapy plays a critical role in the multidisciplinary management of patients with locally advanced or inflammatory breast cancer. It is also accepted that postmastectomy radiation is not required for most women with noninvasive disease or stage I disease. Randomized clinical trials studying radiation treatments for women with stage II or III breast cancer have shown that the addition of radiation after mastectomy can reduce local-regional recurrence rates, which then improves survival. However, other data have indicated that the risk of local-regional recurrence after mastectomy and chemotherapy is low for patients with small tumors and one to three positive lymph nodes, leading some to question whether postmastectomy radiation is useful for this group. A second controversy regards the sequencing of postmastectomy radiation and breast reconstruction. In this article we discuss these controversies, review the data that are relevant, and provide our institutional approaches to these issues.Keywords
Funding Information
- National Cancer Institute Department of Health and Human Services (CA16672, T32CA77050)
- Stanford and Joan Alexander Foundation, Houston, Texas (BC980154)
- USAMRMC Breast Cancer Research Program Career Development
This publication has 23 references indexed in Scilit:
- Predictors of Local-Regional Recurrence After Neoadjuvant Chemotherapy and Mastectomy Without RadiationJournal of Clinical Oncology, 2002
- Pattern of loco-regional and distant failure in patients with breast cancer treated with mastectomy and chemotherapy (+/- Tamoxifen) without radiation: results from five NSABP randomized trialsInternational Journal of Radiation Oncology*Biology*Physics, 2001
- Favourable and unfavourable effects on long-term survival of radiotherapy for early breast cancer: an overview of the randomised trialsThe Lancet, 2000
- Postoperative radiotherapy in high-risk postmenopausal breast-cancer patients given adjuvant tamoxifen: Danish Breast Cancer Cooperative Group DBCG 82c randomised trialPublished by Elsevier ,1999
- Polychemotherapy for early breast cancer: an overview of the randomised trialsThe Lancet, 1998
- Adjuvant Radiotherapy and Chemotherapy in Node-Positive Premenopausal Women with Breast CancerNew England Journal of Medicine, 1997
- Postoperative Radiotherapy in High-Risk Premenopausal Women with Breast Cancer Who Receive Adjuvant ChemotherapyNew England Journal of Medicine, 1997
- Discrepancies between Meta-Analyses and Subsequent Large Randomized, Controlled TrialsNew England Journal of Medicine, 1997
- Evaluation of radiotherapy in high-risk breast cancer patients: Report from the Danish Breast Cancer Cooperative Group (DBCG 82) trialInternational Journal of Radiation Oncology*Biology*Physics, 1990
- Does adequate irradiation of the internal mammary chain and supraclavicular nodes improve survival rates?International Journal of Radiation Oncology*Biology*Physics, 1978